Macular Edema and Macular Degeneration Market Size, Share And Forecast To 2032

1
Macular Edema and Macular Degeneration Global
Market Report 2024
Global Forecast 2024 2033 Market Size, Drivers,
And Trends
Top Market Research Firm 2023! We are honored
to be listed as a top company at the forefront of
research, by the Business Management Review
2
Macular Edema and Macular Degeneration Market
Segments
The Business Research Company segments the
macular edema and macular degeneration market
report as
By Treatment Type
Drug Therapy, Laser Treatment
Macular Edema, Diabetic Macular Edema (DME),
Cystoid Macular Edema (CME), Macular
Degeneration, Dry age-related macular
degeneration, Wet age-related macular degeneration
By Application
Hospitals, Clinics, Other End Users
By End User
3
Market Statistics
The global Macular Edema and Macular Degeneration
market size grew from 8.84 billion in 2023 to
9.65 billion in 2024 at a compound annual growth
rate (CAGR) of 9.1.The Macular Edema and Macular
Degeneration market size is expected to grow
to 12.84 billion in 2028 at a compound annual
growth rate (CAGR) of 7.4.
12.84 B
9.65 B
8.84 B
Click Here To Get A Sample Report
4
Key Market Drivers And Trends
Drivers
The rising diabetes population is expected to
propel the growth of the macular edema and
macular degeneration market going forward.
Trends
Major companies operating in the macular edema
and macular degeneration market are focusing on
developing innovative products such as Vabysmo
(faricimab-svoa) to increase their profitability
in the market.
Region
North America was the largest region in the
Macular Edema and Macular Degeneration market in
2023. The regions covered in the Macular Edema
and Macular Degeneration market analysis report
are Asia-Pacific, Western Europe, Eastern Europe,
North America, South America, Middle East and
Africa.
5
Top Eleven Players In The Market

• Major players in the market are
• F. Hoffmann La Roche Ltd.
• AbbVie Inc.
• Bayer AG
• Novartis AG
• GlaxoSmithKline PLC
• Amgen Inc.

• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Bausch Health Companies Inc.
• Clover Therapeutics Inc.
• Santen Pharmaceutical Co. Ltd

6
7 Reasons Why TBRC Is The Solution You Need

1. Global Macroeconomic Impact Assess global
   economic factors' influence on market growth.
2. Market Size Ratios Explore market size, GDP
   proportions, and expenditure per capita.
3. Global Perspective Reports cover 60 geographies
   for a comprehensive global understanding.
4. Localized Strategies Create region-specific
   strategies aligning with market nuances.
5. Investment Insights Identify growth segments
   through forecast data and market insights.
6. Competitor Benchmarking Compare performance
   against key competitors.
7. Presentation Support Reports offer reliable data
   for internal and external presentations.

7
Americas The Business Research Company, 1295 N
Providence Rd, Macular Edema and Macular
Degeneration, PA 19063, USA ? 1 3156230293
Get In Touch
Europe The Business Research Company 47 Anchorage
Point, 42 Cuba Street, Canary Wharf, London,
England, E14 8NE ? 44 207 1930 708
How ever you want to grow and expand, The
Business Research Company can help as we provide
research consulting solutions for businesses,
government agencies consultancies, and market
research companies.
Asia The Business Research Company, 1st Floor,
Anshu Colors Building, Road Number 1, Park View
Enclave, Jubilee Hills, Hyderabad (India),
500033 ? 91 8897263534
info_at_tbrc.info
8
Your Growth Insights Partner